Ignite Creation Date:
2024-05-05 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00482391
Status:
COMPLETED
Last Update Posted:
2017-05-12
First Post:
2007-06-04
Brief Title:
Doxorubicin and Cyclophosphamide Followed by Paclitaxel Trastuzumab and Lapatinib in Treating Patients With HER2Neu-Overexpressed Breast Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center